Trade Utah Medical Products, Inc. - UTMD CFD

Trading Conditions

• Spread: 0.18
• Long position overnight feeLong position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position-0.026179 %(-US$1.05)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position0.003957 %(US$0.16)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-US$1.05)

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  (US$0.16)

Key Stats

• Prev. Close: 66
• Open: 66.25
• 1-Year Change: -29.47%
• Day's Range: 65.85 - 66.57

Utah Medical Products, Inc. Company profile

About Utah Medical Products, Inc.

Utah Medical Products, Inc. (UTMD) manufactures and markets a range of specialty medical devices. Its product categories include labor and delivery/obstetrics, including fetal monitoring accessories, Vacuum-Assisted Delivery Systems (VAD), and other labor and delivery tools; neonatal intensive care, including DISPOSA-HOOD, DELTRAN PLUS and GESCO; gynecology/urology/electrosurgery, including LETZ System, FINESSE+ Generator, EPITOME and OptiMicro electrosurgical devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, TVUS/HSG-Cath and LUMIN and blood pressure monitoring, including DELTRAN Disposable Pressure Transducer (DPT), and pressure monitoring accessories, components and other molded parts. Its medical devices are sold directly to clinical end-user facilities or a designated stocking distributor for a medical facility. In addition, some of its devices are sold through distributors and national hospital distribution companies.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Utah Medical Products, Inc. revenues increased 20% to $36.1M. Net income increased 44% to $10.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Other income increase of 2% to $129K (income). Dividend per share increased from $0.84 to $0.86.

Equity composition

Common Stock $.01 Par, 3/11, 50M auth., 3,620,000 issd. Insiders own 11.09%. PO 11/82, 1.75M shares @ $1 by Matthew R.White Investment Co. 3/93, 3-for-2 stock split. *During FY'94, UM repurchased & retired 1,134,800 shares.